These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 28935636)

  • 1. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
    Bose M; Almas S; Prabhakar S
    J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
    Wang Y; Li H; Song SP
    Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue.
    Guo Q; Zhong W; Duan A; Sun G; Cui W; Zhuang X; Liu L
    Pharmacol Res; 2019 Jun; 144():151-157. PubMed ID: 30935943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
    Lian H; Cheng Y; Wu X
    Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
    Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
    Dai H; Liu Q; Liu B
    J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
    Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
    J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
    Li Z; Xu J; Xu P; Liu S; Yang Z
    Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
    Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
    J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
    Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
    J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte biology in diabetic nephropathy.
    Li JJ; Kwak SJ; Jung DS; Kim JJ; Yoo TH; Ryu DR; Han SH; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
    Kidney Int Suppl; 2007 Aug; (106):S36-42. PubMed ID: 17653209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research advances in podocyte injury and its role in diabetic nephropathy.
    Li JH; Tao JL; Li H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):590-6. PubMed ID: 21050569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
    Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.